← 產業報告目錄

Blood Gas Analyzer Market by Product (Consumables, Services), Type of Testing (PoC, Conventional), Sample (Arterial, Venous, Capillary Blood), Application (Respiratory, Emergency Care Management), End User (Hospitals, Clinics) - Global Forecast to 2030

出版商 MarketsandMarkets產業別 Medical Devices出版日期 2025-10-13頁數 281報告編號 MD4435

授權報價

Single User Licence$4,950 USD
Multi User Licence$6,650 USD
Corporate User Licence$8,150 USD
Global User Licence$10,000 USD
洽詢購買 申請 Sample

報告摘要

The market was valued at approximately USD 2.70 billion in 2025 and is projected to reach USD 3.38 billion by 2030, growing at a CAGR of 4.6% during the forecast period. The market is witnessing strong growth due to the rising demand for rapid patient assessment in hospital and critical care settings, the need for continuous monitoring of acid-base balance and oxygenation in at-risk patients, and increasing healthcare spending in emerging regions. Additionally, supportive government initiatives to improve hospital diagnostic capabilities and streamline patient care further drive the adoption of blood gas analyzers worldwide. The consumables segment accounted for the largest share of the blood gas analyzer market, by product in 2024. The blood gas analyzer market is segmented into consumables, analyzers, and services based on product. In 2024, the consumables segment held the largest share of the market, as consumables are required for every test performed. The recurring demand for consumables in hospitals, ambulatory care settings, and clinics is a key factor driving the segment’s growth. Hospitals & ASCs segment accounted for the largest share of the blood gas analyzer market, by end user in 2024. The blood gas analyzer market is segmented by end user into Hospitals and ASCs, Clinics, and Other End Users. In 2024, Hospitals and ASCs accounted for the largest market share, as these facilities frequently test blood gas for critically ill patients and those undergoing complex procedures. The high patient volumes and the need for continuous monitoring in these settings drive substantial demand for blood gas analyzers. Asia Pacific is expected to be the fastest-growing region in the blood gas analyzer market. The global blood gas analyzer market is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific region is expected to experience the highest growth during the forecast period. Emerging economies in this region are seeing consistent GDP growth and a notable rise in disposable income, contributing to increased healthcare spending across a broader population base. Additional growth drivers include the rising incidence and prevalence of acute and chronic diseases, modernization of healthcare infrastructure, and the growing adoption of advanced diagnostic technologies, particularly in rural areas. These factors are anticipated to create substantial growth opportunities for blood gas analyzer companies in the Asia Pacific. The breakup of the profile of primary participants in the blood gas analyzer market: • By Company Type: Tier 1 - 40%, Tier 2 - 30%, and Tier 3 - 30% • By Designation: C-level - 28%, D-level - 15%, and Others - 57% • By Region: North America - 51%, Europe - 21%, Asia Pacific - 18%, Latin America - 6%, and Middle East & Africa- 4% The key players in this market are Danaher Corporation (US), F. Hoffmann-La Roche Ltd. (Switzerland), Abbott Laboratories (US), Siemens Healthineers AG (Germany), Werfen S.A. (Spain), Nova Biomedical (US), Medica Corporation (US), Techno Medica Co., Ltd. (Japan), IDEXX Laboratories, Inc. (US), i-SENS, Inc. (South Korea), EDAN Instruments, Inc. (China), Guangzhou Wondfo Biotech Co., Ltd. (China), Labtron Equipment Ltd. (UK), Convergent Technologies GmbH & Co. KG (Germany), Erba Group (Czech Republic), ESCHWEILER GmbH & Co. KG (Germany), Sensa Core Medical Instrumentation Pvt. Ltd. (India), Chengdu Seamaty Technology Co., Ltd. (China), Labdex Ltd. (UK), Meizhou Cornley High-Tech Co., Ltd. (China), Paramedical Srl (Italy), Eaglenos Sciences, Inc. (China), B&E Bio-technology Co., Ltd. (US), Labnics Ltd. (UK) and Fison Instruments Ltd.(UK). Research Coverage: This research report categorizes the blood gas analyzer market by product (consumables, analyzers, and services), by type of testing (point-of-care testing and conventional testing), by sample type (arterial blood, venous blood, and capillary blood), by application (critical care management, respiratory care, emergency care management, and other applications), by end user (hospitals & ASCs, clinics, and other end users), and region (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, opportunities, and challenges influencing the growth of the blood gas analyzer market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, key strategies, acquisitions, and agreements, product & service launches, and recent developments associated with the blood gas analyzer market. This report covers a competitive analysis of upcoming startups in the blood gas analyzer market ecosystem. Reasons to buy this report: The report will help the market leaders/new entrants with information on the closest approximations of the revenue numbers for the overall blood gas analyzer market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the market pulse and provides information on key market drivers, restraints, opportunities, and challenges. The report provides insights into the following pointers: • Analysis of key drivers, such as (rising incidence and prevalence of chronic and acute conditions, advancements in blood gas analyzer technology, inadequacy of alternative techniques, growing demand for point of care blood gas analyzers), opportunities (growth opportunities in developing countries, rising ICU and emergency department admissions), restraints (unfavorable reimbursement policies, complex operations and interpretation of data), and challenges (availability of refurbished analyzers, lack of data analysis software) influencing the growth of the blood gas analyzer market • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the blood gas analyzer market • Market Development: Comprehensive information about lucrative markets—the report analyzes the blood gas analyzer market across varied regions. • Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the blood gas analyzer market Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players such as Danaher Corporation (US), Werfen S.A. (Spain), F. Hoffmann-La Roche Ltd. (Switzerland), Abbott Laboratories (US), and Siemens Healthineers AG (Germany), among others
目錄 Table of Contents
1 INTRODUCTION 28 1.1 STUDY OBJECTIVES 28 1.2 MARKET DEFINITION 28 1.3 STUDY SCOPE 29 1.3.1 MARKETS COVERED & REGIONAL SCOPE 29 1.3.2 INCLUSIONS & EXCLUSIONS 30 1.3.3 YEARS CONSIDERED 31 1.4 CURRENCY CONSIDERED 31 1.5 KEY STAKEHOLDERS 31 1.6 SUMMARY OF CHANGES 32 2 RESEARCH METHODOLOGY 33 2.1 RESEARCH DATA 33 2.2 RESEARCH APPROACH 33 2.2.1 SECONDARY DATA 34 2.2.1.1 Key secondary sources 34 2.2.1.2 Key data from secondary sources 35 2.2.2 PRIMARY DATA 36 2.2.2.1 Primary sources 36 2.2.2.2 Key data from primary sources 37 2.2.2.3 Key industry insights 38 2.2.2.4 Breakdown of primary interviews 38 2.3 MARKET SIZE ESTIMATION 39 2.3.1 BOTTOM-UP APPROACH 40 2.3.1.1 Approach 1: Company revenue estimation approach 40 2.3.1.2 Approach 2: Presentations of companies and primary interviews 40 2.3.1.3 Growth forecast 41 2.3.1.4 CAGR projections 41 2.3.2 TOP-DOWN APPROACH 41 2.4 DATA TRIANGULATION 43 2.5 MARKET SHARE ASSESSMENT 44 2.6 RESEARCH ASSUMPTIONS 44 2.6.1 PARAMETRIC ASSUMPTIONS 44 2.7 RESEARCH LIMITATIONS 44 2.8 RISK ASSESSMENT 45 3 EXECUTIVE SUMMARY 46   4 PREMIUM INSIGHTS 51 4.1 BLOOD GAS ANALYZERS MARKET OVERVIEW 51 4.2 BLOOD GAS ANALYZERS MARKET, BY PRODUCT & SERVICE, 2025 VS. 2030 (USD MILLION) 52 4.3 BLOOD GAS ANALYZERS MARKET, BY TYPE OF TESTING, 2025 VS. 2030 (USD MILLION) 52 4.4 BLOOD GAS ANALYZERS MARKET, BY SAMPLE TYPE, 2025 VS. 2030 (USD MILLION) 53 4.5 BLOOD GAS ANALYZERS MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION) 53 4.6 BLOOD GAS ANALYZERS MARKET, BY END USER, 2025 VS. 2030 (USD MILLION) 54 4.7 BLOOD GAS ANALYZERS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 54 5 MARKET OVERVIEW 55 5.1 INTRODUCTION 55 5.2 MARKET DYNAMICS 55 5.2.1 DRIVERS 56 5.2.1.1 Rising incidence and prevalence of chronic and acute conditions 56 5.2.1.2 Advancements in blood gas analyzer technology 57 5.2.1.3 Inadequacy of alternative techniques 58 5.2.1.4 Growing demand for point-of-care blood gas analyzers 58 5.2.2 RESTRAINTS 58 5.2.2.1 Unfavorable reimbursement policies 58 5.2.2.2 Complex operations & interpretation of data 59 5.2.3 OPPORTUNITIES 59 5.2.3.1 Growth opportunities in developing countries 59 5.2.3.2 Rising ICU and emergency department admissions 60 5.2.4 CHALLENGES 61 5.2.4.1 Availability of refurbished analyzers 61 5.2.4.2 Lack of data analysis software 61 5.3 PRICING ANALYSIS 61 5.3.1 AVERAGE SELLING PRICE TREND OF BLOOD GAS ANALYZERS, 2023–2025 61 5.3.2 AVERAGE SELLING PRICE TREND OF BLOOD GAS ANALYZERS, BY KEY PLAYER, 2023−2025 62 5.3.3 AVERAGE SELLING PRICE TREND OF BLOOD GAS ANALYZERS, BY REGION, 2023−2025 63 5.4 PATENT ANALYSIS 64 5.4.1 LIST OF MAJOR PATENTS 65 5.5 VALUE CHAIN ANALYSIS 66 5.6 SUPPLY CHAIN ANALYSIS 67 5.7 TRADE ANALYSIS 68 5.7.1 TRADE ANALYSIS FOR INSTRUMENTS AND APPARATUS FOR PHYSICAL OR CHEMICAL ANALYSIS 68 5.7.2 IMPORT DATA (HS CODE 9027) 69 5.7.3 EXPORT DATA (HS CODE 9027) 69   5.8 ECOSYSTEM ANALYSIS 70 5.8.1 BLOOD GAS ANALYZERS MARKET: ROLE IN ECOSYSTEM 70 5.9 PORTER’S FIVE FORCES ANALYSIS 71 5.9.1 THREAT OF NEW ENTRANTS 72 5.9.2 THREAT OF SUBSTITUTES 72 5.9.3 BARGAINING POWER OF BUYERS 73 5.9.4 BARGAINING POWER OF SUPPLIERS 73 5.9.5 INTENSITY OF COMPETITIVE RIVALRY 73 5.10 REGULATORY ANALYSIS 73 5.10.1 REGULATORY LANDSCAPE 73 5.10.1.1 North America 73 5.10.1.1.1 US 73 5.10.1.1.2 Canada 73 5.10.1.2 Europe 74 5.10.1.2.1 Germany 74 5.10.1.2.2 UK 75 5.10.1.2.3 France 75 5.10.1.2.4 Italy 75 5.10.1.3 Asia Pacific 75 5.10.1.3.1 China 75 5.10.1.3.2 Japan 76 5.10.1.3.3 India 76 5.10.1.4 Latin America 76 5.10.1.4.1 Brazil 77 5.10.1.4.2 Mexico 77 5.10.1.5 Middle East 77 5.10.1.6 Africa 77 5.10.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 78 5.11 TECHNOLOGY ANALYSIS 79 5.11.1 KEY TECHNOLOGIES 80 5.11.1.1 Electrochemical sensors 80 5.11.2 COMPLEMENTARY TECHNOLOGIES 80 5.11.2.1 Optical sensors 80 5.11.3 ADJACENT TECHNOLOGIES 80 5.11.3.1 Microfluidics 80 5.12 KEY CONFERENCES & EVENTS, 2025–2026 81 5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 82 5.14 KEY STAKEHOLDERS & BUYING CRITERIA 82 5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS 83 5.14.2 BUYING CRITERIA 83 5.15 INVESTMENT & FUNDING SCENARIO 84 5.16 CASE STUDY ANALYSIS 85 5.16.1 CASE STUDY 1: ROLE OF BLOOD GAS ANALYSIS IN EMERGENCY AND CRITICAL CARE 85 5.16.2 CASE STUDY 2: EVALUATION OF A HANDHELD BLOOD GAS ANALYZER IN INTENSIVE CARE SETTINGS 85 5.16.3 CASE STUDY 3: ROLE OF QUALITY MANAGEMENT SYSTEMS IN BLOOD GAS ANALYSIS 86 5.17 IMPACT OF AI/GENERATIVE AI ON BLOOD GAS ANALYZERS MARKET 86 5.17.1 INTRODUCTION 86 5.17.2 MARKET POTENTIAL OF AI 87 5.17.3 AI USE CASES 87 5.17.4 IMPLEMENTATION OF AI, BY KEY COMPANY & CASE 88 5.17.5 FUTURE OF AI IN BLOOD GAS ANALYZERS MARKET 89 5.18 IMPACT OF 2025 US TARIFFS ON BLOOD GAS ANALYZERS MARKET 89 5.18.1 INTRODUCTION 89 5.18.2 KEY TARIFF RATES 89 5.18.3 PRICE IMPACT ANALYSIS 90 5.18.4 KEY IMPACT ON COUNTRY/REGION 90 5.18.4.1 North America 90 5.18.4.2 Europe 91 5.18.4.3 Asia Pacific 91 5.18.5 IMPACT ON END-USE INDUSTRIES 91 5.18.5.1 Hospitals & ASCs 91 5.18.5.2 Clinics 91 6 BLOOD GAS ANALYZERS MARKET, BY PRODUCT & SERVICE 92 6.1 INTRODUCTION 93 6.2 CONSUMABLES 93 6.2.1 RECURRING USE OF CONSUMABLES TO DRIVE MARKET GROWTH 93 6.3 ANALYZERS 97 6.3.1 TECHNOLOGICAL ADVANCEMENTS IN ANALYZERS TO DRIVE ADOPTION 97 6.4 SERVICES 101 6.4.1 INCREASING FOCUS ON OPERATIONAL EFFICIENCY TO PROPEL MARKET EXPANSION 101 7 BLOOD GAS ANALYZERS MARKET, BY TYPE OF TESTING 105 7.1 INTRODUCTION 106 7.2 POINT-OF-CARE TESTING 106 7.2.1 IMPROVED USABILITY AND INNOVATIONS IN POC ANALYZERS TO BOOST ADOPTION OF POINT-OF-CARE TESTING 106 7.3 CONVENTIONAL TESTING 109 7.3.1 GROWING FOCUS ON AUTOMATION AND ACCURACY TO STRENGTHEN MARKET GROWTH 109 8 BLOOD GAS ANALYZERS MARKET, BY SAMPLE TYPE 113 8.1 INTRODUCTION 114 8.2 ARTERIAL BLOOD 114 8.2.1 HIGH UTILIZATION IN CRITICAL CARE SETTINGS TO SUPPORT MARKET GROWTH 114 8.3 VENOUS BLOOD 117 8.3.1 REDUCED INVASIVENESS OF VENOUS BLOOD SAMPLING TO BOOST MARKET ADOPTION 117 8.4 CAPILLARY BLOOD 120 8.4.1 RISING DEMAND FOR PATIENT-CENTRIC CAPILLARY SAMPLING TO DRIVE MARKET EXPANSION 120 9 BLOOD GAS ANALYZERS MARKET, BY APPLICATION 124 9.1 INTRODUCTION 125 9.2 CRITICAL CARE MANAGEMENT 125 9.2.1 INCREASING BURDEN OF ACUTE CRITICAL ILLNESSES TO SUPPORT MARKET EXPANSION 125 9.3 RESPIRATORY CARE 128 9.3.1 RISING PREVALENCE OF RESPIRATORY DISEASES TO DRIVE MARKET GROWTH 128 9.4 EMERGENCY CARE MANAGEMENT 131 9.4.1 INCREASING EMERGENCY DEPARTMENT VISITS TO PROPEL DEMAND FOR BLOOD GAS ANALYZERS 131 9.5 OTHER APPLICATIONS 134 10 BLOOD GAS ANALYZERS MARKET, BY END USER 138 10.1 INTRODUCTION 139 10.2 HOSPITALS & ASCS 139 10.2.1 EXPANDING HEALTHCARE INFRASTRUCTURE TO SPEED UP MARKET GROWTH 139 10.3 CLINICS 142 10.3.1 GROWING USE OF POINT-OF-CARE BLOOD GAS ANALYZERS TO SUPPORT MARKET GROWTH 142 10.4 OTHER END USERS 145 11 BLOOD GAS ANALYZERS MARKET, BY REGION 149 11.1 INTRODUCTION 150 11.2 NORTH AMERICA 150 11.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 154 11.2.2 US 154 11.2.2.1 Increasing prevalence of chronic & respiratory diseases to drive market 154 11.2.3 CANADA 157 11.2.3.1 Rising demand for real-time diagnostics tools to drive market growth 157   11.3 EUROPE 160 11.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 163 11.3.2 GERMANY 163 11.3.2.1 Favorable government policies to propel market growth 163 11.3.3 UK 165 11.3.3.1 Rising emergency department visits to drive market growth 165 11.3.4 FRANCE 168 11.3.4.1 Enhanced healthcare policies and strategic investments in diagnostics to boost market growth 168 11.3.5 ITALY 170 11.3.5.1 Growing chronic disease incidence and government initiatives to boost Italy’s blood gas analyzers market 170 11.3.6 SPAIN 172 11.3.6.1 Growing public health initiatives to augment market growth 172 11.3.7 REST OF EUROPE 175 11.4 ASIA PACIFIC 177 11.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 181 11.4.2 CHINA 181 11.4.2.1 Healthcare infrastructure development and disease burden to support market 181 11.4.3 JAPAN 183 11.4.3.1 Well-developed healthcare system and high geriatric population to aid market growth 183 11.4.4 INDIA 185 11.4.4.1 Initiatives to enhance access to healthcare and improve infrastructure to propel market growth 185 11.4.5 REST OF ASIA PACIFIC 188 11.5 LATIN AMERICA 190 11.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 193 11.5.2 BRAZIL 193 11.5.2.1 Universal healthcare access to drive adoption in Brazil 193 11.5.3 MEXICO 195 11.5.3.1 Rising medical tourism to create strong demand for advanced diagnostic solutions 195 11.5.4 REST OF LATIN AMERICA 198 11.6 MIDDLE EAST & AFRICA 200 11.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 203 11.6.2 KINGDOM OF SAUDI ARABIA 203 11.6.2.1 Rising government healthcare expenditure to boost market 203 11.6.3 UAE 206 11.6.3.1 Improvements in healthcare infrastructure to support growth 206 11.6.4 REST OF MIDDLE EAST & AFRICA 208   12 COMPETITIVE LANDSCAPE 211 12.1 INTRODUCTION 211 12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 211 12.2.1 OVERVIEW OF STRATEGIES DEPLOYED BY PLAYERS IN BLOOD GAS ANALYZERS MARKET 212 12.3 REVENUE ANALYSIS, 2020–2024 214 12.4 MARKET SHARE ANALYSIS, 2024 215 12.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 217 12.5.1 STARS 217 12.5.2 EMERGING LEADERS 217 12.5.3 PERVASIVE PLAYERS 217 12.5.4 PARTICIPANTS 217 12.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 219 12.5.5.1 Company footprint 219 12.5.5.2 Region footprint 220 12.5.5.3 Product & service footprint 220 12.5.5.4 Type of testing footprint 221 12.5.5.5 Sample type footprint 221 12.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 222 12.6.1 PROGRESSIVE COMPANIES 222 12.6.2 RESPONSIVE COMPANIES 222 12.6.3 DYNAMIC COMPANIES 222 12.6.4 STARTING BLOCKS 222 12.6.5 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 224 12.6.5.1 Detailed list of key startups/SMEs 224 12.6.5.2 Competitive benchmarking of startups/SMEs (1/2) 224 12.6.5.3 Competitive benchmarking of startups/SMEs (2/2) 225 12.7 COMPANY VALUATION & FINANCIAL METRICS 225 12.7.1 FINANCIAL METRICS 225 12.7.2 COMPANY VALUATION 226 12.8 BRAND/PRODUCT COMPARISON 226 12.9 COMPETITIVE SCENARIO 227 12.9.1 PRODUCT/SERVICE LAUNCHES 227 12.9.2 DEALS 228 12.9.3 EXPANSIONS 229 13 COMPANY PROFILES 230 13.1 KEY PLAYERS 230 13.1.1 DANAHER CORPORATION 230 13.1.1.1 Business overview 230 13.1.1.2 Products/Services offered 232 13.1.1.3 Recent developments 232 13.1.1.3.1 Deals 232 13.1.1.4 MnM view 233 13.1.1.4.1 Key strengths 233 13.1.1.4.2 Strategic choices 233 13.1.1.4.3 Weaknesses & competitive threats 233 13.1.2 WERFEN S.A. 234 13.1.2.1 Business overview 234 13.1.2.2 Products/Services offered 235 13.1.2.3 Recent developments 236 13.1.2.3.1 Product/Service launches 236 13.1.2.3.2 Expansions 236 13.1.2.4 MnM view 236 13.1.2.4.1 Key strengths 236 13.1.2.4.2 Strategic choices 237 13.1.2.4.3 Weaknesses & competitive threats 237 13.1.3 SIEMENS HEALTHINEERS AG 238 13.1.3.1 Business overview 238 13.1.3.2 Products/Services offered 240 13.1.3.3 Recent developments 240 13.1.3.3.1 Deals 240 13.1.3.3.2 Expansions 241 13.1.3.4 MnM view 241 13.1.3.4.1 Key strengths 241 13.1.3.4.2 Strategic choices 241 13.1.3.4.3 Weaknesses & competitive threats 241 13.1.4 F. HOFFMANN-LA ROCHE LTD. 242 13.1.4.1 Business overview 242 13.1.4.2 Products/Services offered 243 13.1.4.3 Recent developments 244 13.1.4.3.1 Expansions 244 13.1.4.4 MnM view 244 13.1.4.4.1 Key strengths 244 13.1.4.4.2 Strategic choices 244 13.1.4.4.3 Weaknesses & competitive threats 244 13.1.5 ABBOTT LABORATORIES 245 13.1.5.1 Business overview 245 13.1.5.2 Products/Services offered 246 13.1.5.3 MnM view 247 13.1.5.3.1 Key strengths 247 13.1.5.3.2 Strategic choices 247 13.1.5.3.3 Weaknesses & competitive threats 247   13.1.6 NOVA BIOMEDICAL 248 13.1.6.1 Business overview 248 13.1.6.2 Products/Services offered 249 13.1.6.3 Recent developments 249 13.1.6.3.1 Product/Service launches 249 13.1.6.3.2 Deals 250 13.1.6.3.3 Expansions 250 13.1.7 MEDICA CORPORATION 251 13.1.7.1 Business overview 251 13.1.7.2 Products/Services offered 251 13.1.8 TECHNO MEDICA CO., LTD. 252 13.1.8.1 Business overview 252 13.1.8.2 Products/Services offered 253 13.1.9 IDEXX LABORATORIES, INC. 254 13.1.9.1 Business overview 254 13.1.9.2 Products/Services offered 255 13.1.10 I-SENS, INC. 256 13.1.10.1 Business overview 256 13.1.10.2 Products/Services offered 257 13.2 OTHER PLAYERS 258 13.2.1 EDAN INSTRUMENTS, INC. 258 13.2.2 GUANGZHOU WONDFO BIOTECH CO., LTD. 259 13.2.3 LABTRON EQUIPMENT LTD. 260 13.2.4 CONVERGENT TECHNOLOGIES GMBH & CO. KG 261 13.2.5 ERBA GROUP 262 13.2.6 ESCHWEILER GMBH & CO.KG 263 13.2.7 SENSA CORE MEDICAL INSTRUMENTATION PVT. LTD. 264 13.2.8 CHENGDU SEAMATY TECHNOLOGY CO., LTD. 265 13.2.9 LABDEX LTD. 266 13.2.10 MEIZHOU CORNLEY HIGH-TECH CO., LTD. 267 13.2.11 PARAMEDICAL SRL 268 13.2.12 EAGLENOS SCIENCES, INC. 269 13.2.13 B&E BIO-TECHNOLOGY CO., LTD. 270 13.2.14 LABNICS LTD. 271 13.2.15 FISON INSTRUMENTS LTD. 272   14 APPENDIX 273 14.1 DISCUSSION GUIDE 273 14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 277 14.3 CUSTOMIZATION OPTIONS 279 14.4 RELATED REPORTS 279 14.5 AUTHOR DETAILS 280
圖表清單 List of Tables & Figures
TABLE 1 BLOOD GAS ANALYZERS MARKET: INCLUSIONS & EXCLUSIONS 30 TABLE 2 BLOOD GAS ANALYZERS MARKET: KEY DATA FROM PRIMARY SOURCES 37 TABLE 3 AVERAGE SELLING PRICING TREND OF BLOOD GAS BY PRODUCT AFTER ANALYZER, 2023–2025 62 TABLE 4 AVERAGE SELLING PRICE TREND OF BLOOD GAS ANALYZERS, BY KEY PLAYER, 2023–2025 62 TABLE 5 AVERAGE SELLING PRICE TREND OF BLOOD GAS ANALYZERS, BY REGION, 2023–2025 63 TABLE 6 LIST OF MAJOR PATENTS, 2023–2025 65 TABLE 7 IMPORT DATA FOR INSTRUMENTS AND APPARATUS FOR PHYSICAL OR CHEMICAL ANALYSIS (HS CODE 9027), BY COUNTRY, 2020–2024 (USD MILLION) 69 TABLE 8 EXPORT DATA FOR INSTRUMENTS AND APPARATUS FOR PHYSICAL OR CHEMICAL ANALYSIS (HS CODE 9027), BY COUNTRY, 2020–2024 (USD MILLION) 69 TABLE 9 BLOOD GAS ANALYZERS MARKET: ROLE IN ECOSYSTEM 70 TABLE 11 CLASSIFICATION OF IVD DEVICES IN EUROPE 74 TABLE 12 TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS IN JAPAN 76 TABLE 15 ASIA PACIFIC: KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 78 TABLE 18 BLOOD GAS ANALYZERS MARKET: DETAILED LIST OF KEY CONFERENCES & EVENTS, JANUARY 2025–DECEMBER 2026 81 TABLE 19 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF BLOOD GAS ANALYZERS (%) 83 TABLE 20 KEY BUYING CRITERIA FOR BLOOD GAS ANALYZERS 84 TABLE 21 KEY COMPANIES IMPLEMENTING AI 88 TABLE 22 US-ADJUSTED RECIPROCAL TARIFF RATES 89 TABLE 23 BLOOD GAS ANALYZERS MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION) 93 TABLE 24 CONSUMABLES OFFERED BY KEY MARKET PLAYERS 94 TABLE 25 BLOOD GAS ANALYZERS MARKET FOR CONSUMABLES, BY REGION, 2023–2030 (USD MILLION) 95 TABLE 26 NORTH AMERICA: BLOOD GAS ANALYZERS MARKET FOR CONSUMABLES, BY COUNTRY, 2023–2030 (USD MILLION) 95 TABLE 27 EUROPE: BLOOD GAS ANALYZERS MARKET FOR CONSUMABLES, BY COUNTRY, 2023–2030 (USD MILLION) 96 TABLE 28 ASIA PACIFIC: BLOOD GAS ANALYZERS MARKET FOR CONSUMABLES, BY COUNTRY, 2023–2030 (USD MILLION) 96 TABLE 29 LATIN AMERICA: BLOOD GAS ANALYZERS MARKET FOR CONSUMABLES, BY COUNTRY, 2023–2030 (USD MILLION) 97 TABLE 30 MIDDLE EAST & AFRICA: BLOOD GAS ANALYZERS MARKET FOR CONSUMABLES, BY COUNTRY, 2023–2030 (USD MILLION) 97 TABLE 31 ANALYZERS OFFERED BY KEY MARKET PLAYERS 98 TABLE 32 BLOOD GAS ANALYZERS MARKET FOR ANALYZERS, BY REGION, 2023–2030 (USD MILLION) 99 TABLE 33 NORTH AMERICA: BLOOD GAS ANALYZERS MARKET FOR ANALYZERS, BY COUNTRY, 2023–2030 (USD MILLION) 99 TABLE 34 EUROPE: BLOOD GAS ANALYZERS MARKET FOR ANALYZERS, BY COUNTRY, 2023–2030 (USD MILLION) 100 TABLE 35 ASIA PACIFIC: BLOOD GAS ANALYZERS MARKET FOR ANALYZERS, BY COUNTRY, 2023–2030 (USD MILLION) 100 TABLE 36 LATIN AMERICA: BLOOD GAS ANALYZERS MARKET FOR ANALYZERS, BY COUNTRY, 2023–2030 (USD MILLION) 101 TABLE 37 MIDDLE EAST & AFRICA: BLOOD GAS ANALYZERS MARKET FOR ANALYZERS, BY COUNTRY, 2023–2030 (USD MILLION) 101 TABLE 38 BLOOD GAS ANALYZERS MARKET FOR SERVICES, BY REGION, 2023–2030 (USD MILLION) 102 TABLE 39 NORTH AMERICA: BLOOD GAS ANALYZERS MARKET FOR SERVICES, BY COUNTRY, 2023–2030 (USD MILLION) 102 TABLE 40 EUROPE: BLOOD GAS ANALYZERS MARKET FOR SERVICES, BY COUNTRY, 2023–2030 (USD MILLION) 103 TABLE 41 ASIA PACIFIC: BLOOD GAS ANALYZERS MARKET FOR SERVICES, BY COUNTRY, 2023–2030 (USD MILLION) 103 TABLE 42 LATIN AMERICA: BLOOD GAS ANALYZERS MARKET FOR SERVICES, BY COUNTRY, 2023–2030 (USD MILLION) 104 TABLE 43 MIDDLE EAST & AFRICA: BLOOD GAS ANALYZERS MARKET FOR SERVICES, BY COUNTRY, 2023–2030 (USD MILLION) 104 TABLE 44 BLOOD GAS ANALYZERS MARKET, BY TYPE OF TESTING, 2023–2030 (USD MILLION) 106 TABLE 45 KEY POINT-OF-CARE TESTING DEVICES AVAILABLE IN MARKET 107 TABLE 46 BLOOD GAS ANALYZERS MARKET FOR POINT-OF-CARE TESTING, BY REGION, 2023–2030 (USD MILLION) 107 TABLE 47 NORTH AMERICA: BLOOD GAS ANALYZERS MARKET FOR POINT-OF-CARE TESTING, BY COUNTRY, 2023–2030 (USD MILLION) 107 TABLE 48 EUROPE: BLOOD GAS ANALYZERS MARKET FOR POINT-OF-CARE TESTING, BY COUNTRY, 2023–2030 (USD MILLION) 108 TABLE 49 ASIA PACIFIC: BLOOD GAS ANALYZERS MARKET FOR POINT-OF-CARE TESTING, BY COUNTRY, 2023–2030 (USD MILLION) 108 TABLE 50 LATIN AMERICA: BLOOD GAS ANALYZERS MARKET FOR POINT-OF-CARE TESTING, BY COUNTRY, 2023–2030 (USD MILLION) 109 TABLE 51 MIDDLE EAST & AFRICA: BLOOD GAS ANALYZERS MARKET FOR POINT-OF-CARE TESTING, BY COUNTRY, 2023–2030 (USD MILLION) 109 TABLE 52 KEY CONVENTIONAL TESTING DEVICES AVAILABLE IN MARKET 110 TABLE 53 BLOOD GAS ANALYZERS MARKET FOR CONVENTIONAL TESTING, BY REGION, 2023–2030 (USD MILLION) 110 TABLE 54 NORTH AMERICA: BLOOD GAS ANALYZERS MARKET FOR CONVENTIONAL TESTING, BY COUNTRY, 2023–2030 (USD MILLION) 111 TABLE 55 EUROPE: BLOOD GAS ANALYZERS MARKET FOR CONVENTIONAL TESTING, BY COUNTRY, 2023–2030 (USD MILLION) 111 TABLE 56 ASIA PACIFIC: BLOOD GAS ANALYZERS MARKET FOR CONVENTIONAL TESTING, BY COUNTRY, 2023–2030 (USD MILLION) 111 TABLE 57 LATIN AMERICA: BLOOD GAS ANALYZERS MARKET FOR CONVENTIONAL TESTING, BY COUNTRY, 2023–2030 (USD MILLION) 112 TABLE 58 MIDDLE EAST & AFRICA: BLOOD GAS ANALYZERS MARKET FOR CONVENTIONAL TESTING, BY COUNTRY, 2023–2030 (USD MILLION) 112 TABLE 59 BLOOD GAS ANALYZERS MARKET, BY SAMPLE TYPE, 2023–2030 (USD MILLION) 114 TABLE 60 SOME ARTERIAL BLOOD-BASED PRODUCTS AVAILABLE IN MARKET 115 TABLE 61 BLOOD GAS ANALYZERS MARKET FOR ARTERIAL BLOOD SAMPLES, BY REGION, 2023–2030 (USD MILLION) 115 TABLE 62 NORTH AMERICA: BLOOD GAS ANALYZERS MARKET FOR ARTERIAL BLOOD SAMPLES, BY COUNTRY, 2023–2030 (USD MILLION) 115 TABLE 63 EUROPE: BLOOD GAS ANALYZERS MARKET FOR ARTERIAL BLOOD SAMPLES, BY COUNTRY, 2023–2030 (USD MILLION) 116 TABLE 64 ASIA PACIFIC: BLOOD GAS ANALYZERS MARKET FOR ARTERIAL BLOOD SAMPLES, BY COUNTRY, 2023–2030 (USD MILLION) 116 TABLE 65 LATIN AMERICA: BLOOD GAS ANALYZERS MARKET FOR ARTERIAL BLOOD SAMPLES, BY COUNTRY, 2023–2030 (USD MILLION) 117 TABLE 66 MIDDLE EAST & AFRICA: BLOOD GAS ANALYZERS MARKET FOR ARTERIAL BLOOD SAMPLES, BY COUNTRY, 2023–2030 (USD MILLION) 117 TABLE 67 SOME VENOUS BLOOD-BASED PRODUCTS AVAILABLE IN MARKET 118 TABLE 68 BLOOD GAS ANALYZERS MARKET FOR VENOUS BLOOD SAMPLES, BY REGION, 2023–2030 (USD MILLION) 118 TABLE 69 NORTH AMERICA: BLOOD GAS ANALYZERS MARKET FOR VENOUS BLOOD SAMPLES, BY COUNTRY, 2023–2030 (USD MILLION) 119 TABLE 70 EUROPE: BLOOD GAS ANALYZERS MARKET FOR VENOUS BLOOD SAMPLES, BY COUNTRY, 2023–2030 (USD MILLION) 119 TABLE 71 ASIA PACIFIC: BLOOD GAS ANALYZERS MARKET FOR VENOUS BLOOD SAMPLES, BY COUNTRY, 2023–2030 (USD MILLION) 119 TABLE 72 LATIN AMERICA: BLOOD GAS ANALYZERS MARKET FOR VENOUS BLOOD SAMPLES, BY COUNTRY, 2023–2030 (USD MILLION) 120 TABLE 73 MIDDLE EAST & AFRICA: BLOOD GAS ANALYZERS MARKET FOR VENOUS BLOOD SAMPLES, BY COUNTRY, 2023–2030 (USD MILLION) 120 TABLE 74 SOME CAPILLARY BLOOD-BASED PRODUCTS AVAILABLE IN MARKET 121 TABLE 75 BLOOD GAS ANALYZERS MARKET FOR CAPILLARY BLOOD SAMPLES, BY REGION, 2023–2030 (USD MILLION) 121 TABLE 76 NORTH AMERICA: BLOOD GAS ANALYZERS MARKET FOR CAPILLARY BLOOD SAMPLES, BY COUNTRY, 2023–2030 (USD MILLION) 122 TABLE 77 EUROPE: BLOOD GAS ANALYZERS MARKET FOR CAPILLARY BLOOD SAMPLES, BY COUNTRY, 2023–2030 (USD MILLION) 122 TABLE 78 ASIA PACIFIC: BLOOD GAS ANALYZERS MARKET FOR CAPILLARY BLOOD SAMPLES, BY COUNTRY, 2023–2030 (USD MILLION) 122 TABLE 79 LATIN AMERICA: BLOOD GAS ANALYZERS MARKET FOR CAPILLARY BLOOD SAMPLES, BY COUNTRY, 2023–2030 (USD MILLION) 123 TABLE 80 MIDDLE EAST & AFRICA: BLOOD GAS ANALYZERS MARKET FOR CAPILLARY BLOOD SAMPLES, BY COUNTRY, 2023–2030 (USD MILLION) 123 TABLE 81 BLOOD GAS ANALYZERS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 125 TABLE 82 BLOOD GAS ANALYZERS MARKET FOR CRITICAL CARE MANAGEMENT, BY REGION, 2023–2030 (USD MILLION) 126 TABLE 83 NORTH AMERICA: BLOOD GAS ANALYZERS MARKET FOR CRITICAL CARE MANAGEMENT, BY COUNTRY, 2023–2030 (USD MILLION) 126 TABLE 84 EUROPE: BLOOD GAS ANALYZERS MARKET FOR CRITICAL CARE MANAGEMENT, BY COUNTRY, 2023–2030 (USD MILLION) 127 TABLE 85 ASIA PACIFIC: BLOOD GAS ANALYZERS MARKET FOR CRITICAL CARE MANAGEMENT, BY COUNTRY, 2023–2030 (USD MILLION) 127 TABLE 86 LATIN AMERICA: BLOOD GAS ANALYZERS MARKET FOR CRITICAL CARE MANAGEMENT, BY COUNTRY, 2023–2030 (USD MILLION) 128 TABLE 87 MIDDLE EAST & AFRICA: BLOOD GAS ANALYZERS MARKET FOR CRITICAL CARE MANAGEMENT, BY COUNTRY, 2023–2030 (USD MILLION) 128 TABLE 88 BLOOD GAS ANALYZERS MARKET FOR RESPIRATORY CARE, BY REGION, 2023–2030 (USD MILLION) 129 TABLE 89 NORTH AMERICA: BLOOD GAS ANALYZERS MARKET FOR RESPIRATORY CARE, BY COUNTRY, 2023–2030 (USD MILLION) 129 TABLE 90 EUROPE: BLOOD GAS ANALYZERS MARKET FOR RESPIRATORY CARE, BY COUNTRY, 2023–2030 (USD MILLION) 130 TABLE 91 ASIA PACIFIC: BLOOD GAS ANALYZERS MARKET FOR RESPIRATORY CARE, BY COUNTRY, 2023–2030 (USD MILLION) 130 TABLE 92 LATIN AMERICA: BLOOD GAS ANALYZERS MARKET FOR RESPIRATORY CARE, BY COUNTRY, 2023–2030 (USD MILLION) 131 TABLE 93 MIDDLE EAST & AFRICA: BLOOD GAS ANALYZERS MARKET FOR RESPIRATORY CARE, BY COUNTRY, 2023–2030 (USD MILLION) 131 TABLE 94 BLOOD GAS ANALYZERS MARKET FOR EMERGENCY CARE MANAGEMENT, BY REGION, 2023–2030 (USD MILLION) 132 TABLE 95 NORTH AMERICA: BLOOD GAS ANALYZERS MARKET FOR EMERGENCY CARE MANAGEMENT, BY COUNTRY, 2023–2030 (USD MILLION) 132 TABLE 96 EUROPE: BLOOD GAS ANALYZERS MARKET FOR EMERGENCY CARE MANAGEMENT, BY COUNTRY, 2023–2030 (USD MILLION) 133 TABLE 97 ASIA PACIFIC: BLOOD GAS ANALYZERS MARKET FOR EMERGENCY CARE MANAGEMENT, BY COUNTRY, 2023–2030 (USD MILLION) 133 TABLE 98 LATIN AMERICA: BLOOD GAS ANALYZERS MARKET FOR EMERGENCY CARE MANAGEMENT, BY COUNTRY, 2023–2030 (USD MILLION) 134 TABLE 99 MIDDLE EAST & AFRICA: BLOOD GAS ANALYZERS MARKET FOR EMERGENCY CARE MANAGEMENT, BY COUNTRY, 2023–2030 (USD MILLION) 134 TABLE 100 BLOOD GAS ANALYZERS MARKET FOR OTHER APPLICATIONS, BY REGION, 2023–2030 (USD MILLION) 135 TABLE 101 NORTH AMERICA: BLOOD GAS ANALYZERS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 135 TABLE 102 EUROPE: BLOOD GAS ANALYZERS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 136 TABLE 103 ASIA PACIFIC: BLOOD GAS ANALYZERS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 136 TABLE 104 LATIN AMERICA: BLOOD GAS ANALYZERS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 137 TABLE 105 MIDDLE EAST & AFRICA: BLOOD GAS ANALYZERS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 137 TABLE 106 BLOOD GAS ANALYZERS MARKET, BY END USER, 2023–2030 (USD MILLION) 139 TABLE 107 BLOOD GAS ANALYZERS MARKET FOR HOSPITALS & ASCS, BY REGION, 2023–2030 (USD MILLION) 140 TABLE 108 NORTH AMERICA: BLOOD GAS ANALYZERS MARKET FOR HOSPITALS & ASCS, BY COUNTRY, 2023–2030 (USD MILLION) 140 TABLE 109 EUROPE: BLOOD GAS ANALYZERS MARKET FOR HOSPITALS & ASCS, BY COUNTRY, 2023–2030 (USD MILLION) 141 TABLE 110 ASIA PACIFIC: BLOOD GAS ANALYZERS MARKET FOR HOSPITALS & ASCS, BY COUNTRY, 2023–2030 (USD MILLION) 141 TABLE 111 LATIN AMERICA: BLOOD GAS ANALYZERS MARKET FOR HOSPITALS & ASCS, BY COUNTRY, 2023–2030 (USD MILLION) 142 TABLE 112 MIDDLE EAST & AFRICA: BLOOD GAS ANALYZERS MARKET FOR HOSPITALS & ASCS, BY COUNTRY, 2023–2030 (USD MILLION) 142 TABLE 113 BLOOD GAS ANALYZERS MARKET FOR CLINICS, BY REGION, 2023–2030 (USD MILLION) 143 TABLE 114 NORTH AMERICA: BLOOD GAS ANALYZERS MARKET FOR CLINICS, BY COUNTRY, 2023–2030 (USD MILLION) 143 TABLE 115 EUROPE: BLOOD GAS ANALYZERS MARKET FOR CLINICS, BY COUNTRY, 2023–2030 (USD MILLION) 144 TABLE 116 ASIA PACIFIC: BLOOD GAS ANALYZERS MARKET FOR CLINICS, BY COUNTRY, 2023–2030 (USD MILLION) 144 TABLE 117 LATIN AMERICA: BLOOD GAS ANALYZERS MARKET FOR CLINICS, BY COUNTRY, 2023–2030 (USD MILLION) 145 TABLE 118 MIDDLE EAST & AFRICA: BLOOD GAS ANALYZERS MARKET FOR CLINICS, BY COUNTRY, 2023–2030 (USD MILLION) 145 TABLE 119 BLOOD GAS ANALYZERS MARKET FOR OTHER END USERS, BY REGION, 2023–2030 (USD MILLION) 146 TABLE 120 NORTH AMERICA: BLOOD GAS ANALYZERS MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION) 146 TABLE 121 EUROPE: BLOOD GAS ANALYZERS MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION) 147 TABLE 122 ASIA PACIFIC: BLOOD GAS ANALYZERS MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION) 147 TABLE 123 LATIN AMERICA: BLOOD GAS ANALYZERS MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION) 148 TABLE 124 MIDDLE EAST & AFRICA: BLOOD GAS ANALYZERS MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION) 148 TABLE 125 BLOOD GAS ANALYZERS MARKET, BY REGION, 2023–2030 (USD MILLION) 150 TABLE 126 NORTH AMERICA: BLOOD GAS ANALYZERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 152 TABLE 127 NORTH AMERICA: BLOOD GAS ANALYZERS MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION) 152 TABLE 128 NORTH AMERICA: BLOOD GAS ANALYZERS MARKET, BY TYPE OF TESTING, 2023–2030 (USD MILLION) 152 TABLE 129 NORTH AMERICA: BLOOD GAS ANALYZERS MARKET, BY SAMPLE TYPE, 2023–2030 (USD MILLION) 153 TABLE 130 NORTH AMERICA: BLOOD GAS ANALYZERS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 153 TABLE 131 NORTH AMERICA: BLOOD GAS ANALYZERS MARKET, BY END USER, 2023–2030 (USD MILLION) 153 TABLE 132 NORTH AMERICA: MACROECONOMIC INDICATORS 154 TABLE 133 US: NUMBER OF EMERGENCY DEPARTMENT VISITS, 2023–2030 155 TABLE 134 US: BLOOD GAS ANALYZERS MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION) 156 TABLE 135 US: BLOOD GAS ANALYZERS MARKET, BY TYPE OF TESTING, 2023–2030 (USD MILLION) 156 TABLE 136 US: BLOOD GAS ANALYZERS MARKET, BY SAMPLE TYPE, 2023–2030 (USD MILLION) 156 TABLE 137 US: BLOOD GAS ANALYZERS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 157 TABLE 138 US: BLOOD GAS ANALYZERS MARKET, BY END USER, 2023–2030 (USD MILLION) 157 TABLE 139 CANADA: BLOOD GAS ANALYZERS MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION) 158 TABLE 140 CANADA: BLOOD GAS ANALYZERS MARKET, BY TYPE OF TESTING, 2023–2030 (USD MILLION) 158 TABLE 141 CANADA: BLOOD GAS ANALYZERS MARKET, BY SAMPLE TYPE, 2023–2030 (USD MILLION) 159 TABLE 142 CANADA: BLOOD GAS ANALYZERS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 159 TABLE 143 CANADA: BLOOD GAS ANALYZERS MARKET, BY END USER, 2023–2030 (USD MILLION) 159 TABLE 144 EUROPE: BLOOD GAS ANALYZERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 160 TABLE 145 EUROPE: BLOOD GAS ANALYZERS MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION) 161 TABLE 146 EUROPE: BLOOD GAS ANALYZERS MARKET, BY TYPE OF TESTING, 2023–2030 (USD MILLION) 161 TABLE 147 EUROPE: BLOOD GAS ANALYZERS MARKET, BY SAMPLE TYPE, 2023–2030 (USD MILLION) 161 TABLE 148 EUROPE: BLOOD GAS ANALYZERS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 162 TABLE 149 EUROPE: BLOOD GAS ANALYZERS MARKET, BY END USER, 2023–2030 (USD MILLION) 162 TABLE 150 EUROPE: MACROECONOMIC INDICATORS 162 TABLE 151 GERMANY: BLOOD GAS ANALYZERS MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION) 164 TABLE 152 GERMANY: BLOOD GAS ANALYZERS MARKET, BY TYPE OF TESTING, 2023–2030 (USD MILLION) 164 TABLE 153 GERMANY: BLOOD GAS ANALYZERS MARKET, BY SAMPLE TYPE, 2023–2030 (USD MILLION) 164 TABLE 154 GERMANY: BLOOD GAS ANALYZERS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 165 TABLE 155 GERMANY: BLOOD GAS ANALYZERS MARKET, BY END USER, 2023–2030 (USD MILLION) 165 TABLE 156 UK: BLOOD GAS ANALYZERS MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION) 166 TABLE 157 UK: BLOOD GAS ANALYZERS MARKET, BY TYPE OF TESTING, 2023–2030 (USD MILLION) 166 TABLE 158 UK: BLOOD GAS ANALYZERS MARKET, BY SAMPLE TYPE, 2023–2030 (USD MILLION) 167 TABLE 159 UK: BLOOD GAS ANALYZERS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 167 TABLE 160 UK: BLOOD GAS ANALYZERS MARKET, BY END USER, 2023–2030 (USD MILLION) 167 TABLE 161 FRANCE: BLOOD GAS ANALYZERS MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION) 168 TABLE 162 FRANCE: BLOOD GAS ANALYZERS MARKET, BY TYPE OF TESTING, 2023–2030 (USD MILLION) 169 TABLE 163 FRANCE: BLOOD GAS ANALYZERS MARKET, BY SAMPLE TYPE, 2023–2030 (USD MILLION) 169 TABLE 164 FRANCE: BLOOD GAS ANALYZERS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 169 TABLE 165 FRANCE: BLOOD GAS ANALYZERS MARKET, BY END USER, 2023–2030 (USD MILLION) 170 TABLE 166 ITALY: BLOOD GAS ANALYZERS MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION) 171 TABLE 167 ITALY: BLOOD GAS ANALYZERS MARKET, BY TYPE OF TESTING, 2023–2030 (USD MILLION) 171 TABLE 168 ITALY: BLOOD GAS ANALYZERS MARKET, BY SAMPLE TYPE, 2023–2030 (USD MILLION) 171 TABLE 169 ITALY: BLOOD GAS ANALYZERS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 172 TABLE 170 ITALY: BLOOD GAS ANALYZERS MARKET, BY END USER, 2023–2030 (USD MILLION) 172 TABLE 171 SPAIN: BLOOD GAS ANALYZERS MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION) 173 TABLE 172 SPAIN: BLOOD GAS ANALYZERS MARKET, BY TYPE OF TESTING, 2023–2030 (USD MILLION) 173 TABLE 173 SPAIN: BLOOD GAS ANALYZERS MARKET, BY SAMPLE TYPE, 2023–2030 (USD MILLION) 174 TABLE 174 SPAIN: BLOOD GAS ANALYZERS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 174 TABLE 175 SPAIN: BLOOD GAS ANALYZERS MARKET, BY END USER, 2023–2030 (USD MILLION) 174 TABLE 176 REST OF EUROPE: BLOOD GAS ANALYZERS MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION) 175 TABLE 177 REST OF EUROPE: BLOOD GAS ANALYZERS MARKET, BY TYPE OF TESTING, 2023–2030 (USD MILLION) 176 TABLE 178 REST OF EUROPE: BLOOD GAS ANALYZERS MARKET, BY SAMPLE TYPE, 2023–2030 (USD MILLION) 176 TABLE 179 REST OF EUROPE: BLOOD GAS ANALYZERS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 176 TABLE 180 REST OF EUROPE: BLOOD GAS ANALYZERS MARKET, BY END USER, 2023–2030 (USD MILLION) 177 TABLE 181 ASIA PACIFIC: BLOOD GAS ANALYZERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 178 TABLE 182 ASIA PACIFIC: BLOOD GAS ANALYZERS MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION) 179 TABLE 183 ASIA PACIFIC: BLOOD GAS ANALYZERS MARKET, BY TYPE OF TESTING, 2023–2030 (USD MILLION) 179 TABLE 184 ASIA PACIFIC: BLOOD GAS ANALYZERS MARKET, BY SAMPLE TYPE, 2023–2030 (USD MILLION) 179 TABLE 185 ASIA PACIFIC: BLOOD GAS ANALYZERS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 180 TABLE 186 ASIA PACIFIC: BLOOD GAS ANALYZERS MARKET, BY END USER, 2023–2030 (USD MILLION) 180 TABLE 187 ASIA PACIFIC: MACROECONOMIC INDICATORS 180 TABLE 188 CHINA: BLOOD GAS ANALYZERS MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION) 182 TABLE 189 CHINA: BLOOD GAS ANALYZERS MARKET, BY TYPE OF TESTING, 2023–2030 (USD MILLION) 182 TABLE 190 CHINA: BLOOD GAS ANALYZERS MARKET, BY SAMPLE TYPE, 2023–2030 (USD MILLION) 182 TABLE 191 CHINA: BLOOD GAS ANALYZERS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 183 TABLE 192 CHINA: BLOOD GAS ANALYZERS MARKET, BY END USER, 2023–2030 (USD MILLION) 183 TABLE 193 JAPAN: BLOOD GAS ANALYZERS MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION) 184 TABLE 194 JAPAN: BLOOD GAS ANALYZERS MARKET, BY TYPE OF TESTING, 2023–2030 (USD MILLION) 184 TABLE 195 JAPAN: BLOOD GAS ANALYZERS MARKET, BY SAMPLE TYPE, 2023–2030 (USD MILLION) 184 TABLE 196 JAPAN: BLOOD GAS ANALYZERS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 185 TABLE 197 JAPAN: BLOOD GAS ANALYZERS MARKET, BY END USER, 2023–2030 (USD MILLION) 185 TABLE 198 INDIA: BLOOD GAS ANALYZERS MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION) 186 TABLE 199 INDIA: BLOOD GAS ANALYZERS MARKET, BY TYPE OF TESTING, 2023–2030 (USD MILLION) 186 TABLE 200 INDIA: BLOOD GAS ANALYZERS MARKET, BY SAMPLE TYPE, 2023–2030 (USD MILLION) 187 TABLE 201 INDIA: BLOOD GAS ANALYZERS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 187 TABLE 202 INDIA: BLOOD GAS ANALYZERS MARKET, BY END USER, 2023–2030 (USD MILLION) 187 TABLE 203 REST OF ASIA PACIFIC: BLOOD GAS ANALYZERS MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION) 188 TABLE 204 REST OF ASIA PACIFIC: BLOOD GAS ANALYZERS MARKET, BY TYPE OF TESTING, 2023–2030 (USD MILLION) 189 TABLE 205 REST OF ASIA PACIFIC: BLOOD GAS ANALYZERS MARKET, BY SAMPLE TYPE, 2023–2030 (USD MILLION) 189 TABLE 206 REST OF ASIA PACIFIC: BLOOD GAS ANALYZERS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 189 TABLE 207 REST OF ASIA PACIFIC: BLOOD GAS ANALYZERS MARKET, BY END USER, 2023–2030 (USD MILLION) 190 TABLE 208 LATIN AMERICA: BLOOD GAS ANALYZERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 191 TABLE 209 LATIN AMERICA: BLOOD GAS ANALYZERS MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION) 191 TABLE 210 LATIN AMERICA: BLOOD GAS ANALYZERS MARKET, BY TYPE OF TESTING, 2023–2030 (USD MILLION) 191 TABLE 211 LATIN AMERICA: BLOOD GAS ANALYZERS MARKET, BY SAMPLE TYPE, 2023–2030 (USD MILLION) 192 TABLE 212 LATIN AMERICA: BLOOD GAS ANALYZERS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 192 TABLE 213 LATIN AMERICA: BLOOD GAS ANALYZERS MARKET, BY END USER, 2023–2030 (USD MILLION) 192 TABLE 214 LATIN AMERICA: MACROECONOMIC INDICATORS 193 TABLE 215 BRAZIL: BLOOD GAS ANALYZERS MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION) 194 TABLE 216 BRAZIL: BLOOD GAS ANALYZERS MARKET, BY TYPE OF TESTING, 2023–2030 (USD MILLION) 194 TABLE 217 BRAZIL: BLOOD GAS ANALYZERS MARKET, BY SAMPLE TYPE, 2023–2030 (USD MILLION) 194 TABLE 218 BRAZIL: BLOOD GAS ANALYZERS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 195 TABLE 219 BRAZIL: BLOOD GAS ANALYZERS MARKET, BY END USER, 2023–2030 (USD MILLION) 195 TABLE 220 MEXICO: BLOOD GAS ANALYZERS MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION) 196 TABLE 221 MEXICO: BLOOD GAS ANALYZERS MARKET, BY TYPE OF TESTING, 2023–2030 (USD MILLION) 196 TABLE 222 MEXICO: BLOOD GAS ANALYZERS MARKET, BY SAMPLE TYPE, 2023–2030 (USD MILLION) 197 TABLE 223 MEXICO: BLOOD GAS ANALYZERS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 197 TABLE 224 MEXICO: BLOOD GAS ANALYZERS MARKET, BY END USER, 2023–2030 (USD MILLION) 197 TABLE 225 REST OF LATIN AMERICA: BLOOD GAS ANALYZERS MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION) 198 TABLE 226 REST OF LATIN AMERICA: BLOOD GAS ANALYZERS MARKET, BY TYPE OF TESTING, 2023–2030 (USD MILLION) 199 TABLE 227 REST OF LATIN AMERICA: BLOOD GAS ANALYZERS MARKET, BY SAMPLE TYPE, 2023–2030 (USD MILLION) 199 TABLE 228 REST OF LATIN AMERICA: BLOOD GAS ANALYZERS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 199 TABLE 229 REST OF LATIN AMERICA: BLOOD GAS ANALYZERS MARKET, BY END USER, 2023–2030 (USD MILLION) 200 TABLE 230 MIDDLE EAST & AFRICA: BLOOD GAS ANALYZERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 201 TABLE 231 MIDDLE EAST & AFRICA: BLOOD GAS ANALYZERS MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION) 201 TABLE 232 MIDDLE EAST & AFRICA: BLOOD GAS ANALYZERS MARKET, BY TYPE OF TESTING, 2023–2030 (USD MILLION) 201 TABLE 233 MIDDLE EAST & AFRICA: BLOOD GAS ANALYZERS MARKET, BY SAMPLE TYPE, 2023–2030 (USD MILLION) 202 TABLE 234 MIDDLE EAST & AFRICA: BLOOD GAS ANALYZERS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 202 TABLE 235 MIDDLE EAST & AFRICA: BLOOD GAS ANALYZERS MARKET, BY END USER, 2023–2030 (USD MILLION) 202 TABLE 236 MIDDLE EAST & AFRICA: MACROECONOMIC INDICATORS 203 TABLE 237 KINGDOM OF SAUDI ARABIA: BLOOD GAS ANALYZERS MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION) 204 TABLE 238 KINGDOM OF SAUDI ARABIA: BLOOD GAS ANALYZERS MARKET, BY TYPE OF TESTING, 2023–2030 (USD MILLION) 204 TABLE 239 KINGDOM OF SAUDI ARABIA: BLOOD GAS ANALYZERS MARKET, BY SAMPLE TYPE, 2023–2030 (USD MILLION) 205 TABLE 240 KINGDOM OF SAUDI ARABIA: BLOOD GAS ANALYZERS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 205 TABLE 241 KINGDOM OF SAUDI ARABIA: BLOOD GAS ANALYZERS MARKET, BY END USER, 2023–2030 (USD MILLION) 205 TABLE 242 UAE: BLOOD GAS ANALYZERS MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION) 206 TABLE 243 UAE: BLOOD GAS ANALYZERS MARKET, BY TYPE OF TESTING, 2023–2030 (USD MILLION) 206 TABLE 244 UAE: BLOOD GAS ANALYZERS MARKET, BY SAMPLE TYPE, 2023–2030 (USD MILLION) 207 TABLE 245 UAE: BLOOD GAS ANALYZERS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 207 TABLE 246 UAE: BLOOD GAS ANALYZERS MARKET, BY END USER, 2023–2030 (USD MILLION) 207 TABLE 247 REST OF MIDDLE EAST & AFRICA: BLOOD GAS ANALYZERS MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION) 208 TABLE 248 REST OF MIDDLE EAST & AFRICA: BLOOD GAS ANALYZERS MARKET, BY TYPE OF TESTING, 2023–2030 (USD MILLION) 209 TABLE 249 REST OF MIDDLE EAST & AFRICA: BLOOD GAS ANALYZERS MARKET, BY SAMPLE TYPE, 2023–2030 (USD MILLION) 209 TABLE 250 REST OF MIDDLE EAST & AFRICA: BLOOD GAS ANALYZERS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 209 TABLE 251 REST OF MIDDLE EAST & AFRICA: BLOOD GAS ANALYZERS MARKET, BY END USER, 2023–2030 (USD MILLION) 210 TABLE 252 OVERVIEW OF STRATEGIES DEPLOYED BY KEY COMPANIES IN BLOOD GAS ANALYZERS MARKET, JANUARY 2022−SEPTEMBER 2025 212 TABLE 253 BLOOD GAS ANALYZERS MARKET: DEGREE OF COMPETITION 215 TABLE 254 BLOOD GAS ANALYZERS MARKET: REGION FOOTPRINT 220 TABLE 255 BLOOD GAS ANALYZERS MARKET: PRODUCT & SERVICE FOOTPRINT 220 TABLE 256 BLOOD GAS ANALYZERS MARKET: TYPE OF TESTING FOOTPRINT 221 TABLE 257 BLOOD GAS ANALYZERS MARKET: SAMPLE TYPE FOOTPRINT 221 TABLE 258 BLOOD GAS ANALYZERS MARKET: DETAILED LIST OF KEY STARTUPS/SMES 224 TABLE 259 BLOOD GAS ANALYZERS MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES (1/2) 224 TABLE 260 BLOOD GAS ANALYZERS MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES (2/2) 225 TABLE 261 BLOOD GAS ANALYZERS MARKET: PRODUCT/SERVICE LAUNCHES, JANUARY 2022–SEPTEMBER 2025 227 TABLE 262 BLOOD GAS ANALYZERS MARKET: DEALS, JANUARY 2022–SEPTEMBER 2025 228 TABLE 263 BLOOD GAS ANALYZERS MARKET: EXPANSIONS, JANUARY 2022–SEPTEMBER 2025 229 TABLE 264 DANAHER CORPORATION: COMPANY OVERVIEW 230 TABLE 265 DANAHER CORPORATION: PRODUCTS/SERVICES OFFERED 232 TABLE 266 DANAHER CORPORATION: DEALS, JANUARY 2022–SEPTEMBER 2025 232 TABLE 267 WERFEN S.A.: COMPANY OVERVIEW 234 TABLE 268 WERFEN S.A.: PRODUCTS/SERVICES OFFERED 235 TABLE 269 WERFEN S.A.: PRODUCT/SERVICE LAUNCHES, JANUARY 2022–SEPTEMBER 2025 236 TABLE 270 WERFEN S.A.: EXPANSIONS, JANUARY 2022−SEPTEMBER 2025 236 TABLE 271 SIEMENS HEALTHINEERS AG: COMPANY OVERVIEW 238 TABLE 272 SIEMENS HEALTHINEERS AG: PRODUCTS/SERVICES OFFERED 240 TABLE 273 SIEMENS HEALTHINEERS AG: DEALS, JANUARY 2022–SEPTEMBER 2025 240 TABLE 274 SIEMENS HEALTHINEERS AG: EXPANSIONS, JANUARY 2022−SEPTEMBER 2025 241 TABLE 275 F. HOFFMANN-LA ROCHE LTD.: COMPANY OVERVIEW 242 TABLE 276 F. HOFFMANN-LA ROCHE LTD.: PRODUCTS/SERVICES OFFERED 243 TABLE 277 F. HOFFMANN-LA ROCHE LTD.: EXPANSIONS, JANUARY 2022–SEPTEMBER 2025 244 TABLE 278 ABBOTT LABORATORIES: COMPANY OVERVIEW 245 TABLE 279 ABBOTT LABORATORIES: PRODUCTS/SERVICES OFFERED 246 TABLE 280 NOVA BIOMEDICAL: COMPANY OVERVIEW 248 TABLE 281 NOVA BIOMEDICAL: PRODUCTS/SERVICES OFFERED 249 TABLE 282 NOVA BIOMEDICAL: PRODUCT/SERVICE LAUNCHES, JANUARY 2022–SEPTEMBER 2025 249 TABLE 283 NOVA BIOMEDICAL: DEALS, JANUARY 2022–SEPTEMBER 2025 250 TABLE 284 NOVA BIOMEDICAL: EXPANSIONS, JANUARY 2022−SEPTEMBER 2025 250 TABLE 285 MEDICA CORPORATION: COMPANY OVERVIEW 251 TABLE 286 MEDICA CORPORATION: PRODUCTS/SERVICES OFFERED 251 TABLE 287 TECHNO MEDICA CO., LTD.: COMPANY OVERVIEW 252 TABLE 288 TECHNO MEDICA CO., LTD.: PRODUCTS/SERVICES OFFERED 253 TABLE 289 IDEXX LABORATORIES, INC.: COMPANY OVERVIEW 254 TABLE 290 IDEXX LABORATORIES, INC: PRODUCTS/SERVICES OFFERED 255 TABLE 291 I-SENS, INC.: COMPANY OVERVIEW 256 TABLE 292 I-SENS, INC.: PRODUCTS/SERVICES OFFERED 257 TABLE 293 EDAN INSTRUMENTS, INC.: COMPANY OVERVIEW 258 TABLE 294 GUANGZHOU WONDFO BIOTECH CO., LTD.: COMPANY OVERVIEW 259 TABLE 295 LABTRON EQUIPMENT LTD.: COMPANY OVERVIEW 260 TABLE 296 CONVERGENT TECHNOLOGIES GMBH & CO. KG: COMPANY OVERVIEW 261 TABLE 297 ERBA GROUP: COMPANY OVERVIEW 262 TABLE 298 ESCHWEILER GMBH & CO.KG: COMPANY OVERVIEW 263 TABLE 299 SENSA CORE MEDICAL INSTRUMENTATION PVT. LTD.: COMPANY OVERVIEW 264 TABLE 300 CHENGDU SEAMATY TECHNOLOGY CO., LTD.: COMPANY OVERVIEW 265 TABLE 301 LABDEX LTD.: COMPANY OVERVIEW 266 TABLE 302 MEIZHOU CORNLEY HIGH-TECH CO., LTD.: COMPANY OVERVIEW 267 TABLE 303 PARAMEDICAL SRL: COMPANY OVERVIEW 268 TABLE 304 EAGLENOS SCIENCES, INC.: COMPANY OVERVIEW 269 TABLE 305 B&E BIO-TECHNOLOGY CO., LTD.: COMPANY OVERVIEW 270 TABLE 306 LABNICS LTD.: COMPANY OVERVIEW 271 TABLE 307 FISON INSTRUMENTS LTD.: COMPANY OVERVIEW 272 FIGURE 1 BLOOD GAS ANALYZERS MARKET SEGMENTATION & REGIONAL SCOPE 29 FIGURE 2 BLOOD GAS ANALYZERS MARKET: RESEARCH DESIGN METHODOLOGY 33 FIGURE 3 PRIMARY SOURCES 36 FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 38 FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 39 FIGURE 6 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH 40 FIGURE 7 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 41 FIGURE 8 BLOOD GAS ANALYZERS MARKET: TOP-DOWN APPROACH 42 FIGURE 9 DATA TRIANGULATION METHODOLOGY 43 FIGURE 10 BLOOD GAS ANALYZERS MARKET: RESEARCH ASSUMPTIONS 44 FIGURE 11 BLOOD GAS ANALYZERS MARKET, BY PRODUCT & SERVICE, 2025 VS. 2030 (USD MILLION) 46 FIGURE 12 BLOOD GAS ANALYZERS MARKET, BY TYPE OF TESTING, 2025 VS. 2030 (USD MILLION) 47 FIGURE 13 BLOOD GAS ANALYZERS MARKET, BY SAMPLE TYPE, 2025 VS. 2030 (USD MILLION) 47 FIGURE 14 BLOOD GAS ANALYZERS MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION) 48 FIGURE 15 BLOOD GAS ANALYZERS MARKET, BY END USER, 2025 VS. 2030 (USD MILLION) 49 FIGURE 16 BLOOD GAS ANALYZERS MARKET, BY REGION, 2025 VS. 2030 (USD MILLION) 49 FIGURE 17 GROWING BURDEN OF CHRONIC AND ACUTE DISEASES AND ADVANCEMENTS IN POINT-OF-CARE DIAGNOSTICS TO DRIVE MARKET 51 FIGURE 18 CONSUMABLES SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD 52 FIGURE 19 POINT-OF-CARE TESTING SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD 52 FIGURE 20 ARTERIAL BLOOD SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD 53 FIGURE 21 CRITICAL CARE MANAGEMENT SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD 53 FIGURE 22 HOSPITALS & ASCS SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD 54 FIGURE 23 ASIA PACIFIC TO REGISTER HIGHEST GROWTH RATE IN BLOOD GAS ANALYZERS MARKET DURING FORECAST PERIOD 54 FIGURE 24 BLOOD GAS ANALYZERS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 55 FIGURE 25 PATENT ANALYSIS FOR BLOOD GAS ANALYZERS (JANUARY 2014–DECEMBER 2024) 64 FIGURE 26 VALUE CHAIN ANALYSIS OF BLOOD GAS ANALYZERS MARKET: MAJOR VALUE ADDED DURING MANUFACTURING & ASSEMBLY PHASES 66 FIGURE 27 BLOOD GAS ANALYZERS MARKET: SUPPLY CHAIN ANALYSIS 68 FIGURE 28 BLOOD GAS ANALYZERS MARKET: ECOSYSTEM ANALYSIS 70 FIGURE 29 BLOOD GAS ANALYZERS MARKET: PORTER’S FIVE FORCES ANALYSIS 72 FIGURE 30 BLOOD GAS ANALYZERS MARKET: TRENDS & DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 82 FIGURE 31 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF BLOOD GAS ANALYZERS 83 FIGURE 32 KEY BUYING CRITERIA FOR BLOOD GAS ANALYZERS 83 FIGURE 33 NUMBER OF DEALS & FUNDING ACTIVITIES IN BLOOD GAS ANALYZERS MARKET (2021–2024) 84 FIGURE 34 MARKET POTENTIAL OF AI IN BLOOD GAS ANALYZERS MARKET 87 FIGURE 35 NORTH AMERICA: BLOOD GAS ANALYZERS MARKET SNAPSHOT 151 FIGURE 36 ASIA PACIFIC: BLOOD GAS ANALYZERS MARKET SNAPSHOT 178 FIGURE 37 REVENUE ANALYSIS OF KEY PLAYERS IN BLOOD GAS ANALYZERS MARKET (2020–2024) 214 FIGURE 38 MARKET SHARE ANALYSIS OF KEY PLAYERS IN BLOOD GAS ANALYZERS MARKET (2024) 215 FIGURE 39 BLOOD GAS ANALYZERS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024 218 FIGURE 40 BLOOD GAS ANALYZERS MARKET: COMPANY FOOTPRINT 219 FIGURE 41 BLOOD GAS ANALYZERS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 223 FIGURE 42 EV/EBITDA OF KEY VENDORS 225 FIGURE 43 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS 226 FIGURE 44 BLOOD GAS ANALYZERS MARKET: BRAND COMPARISON FOR ANALYZERS 226 FIGURE 45 DANAHER CORPORATION: COMPANY SNAPSHOT (2024) 231 FIGURE 46 WERFEN S.A: COMPANY SNAPSHOT (2024) 235 FIGURE 47 SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT (2024) 239 FIGURE 48 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2024) 243 FIGURE 49 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2024) 246 FIGURE 50 TECHNO MEDICA CO., LTD.: COMPANY SNAPSHOT (2025) 252 FIGURE 51 IDEXX LABORATORIES, INC.: COMPANY SNAPSHOT (2024) 255 FIGURE 52 I-SENS, INC.: COMPANY SNAPSHOT (2024) 256

同分類最新報告(醫療器材)

量子訊息有限公司為 MarketsandMarkets 在台灣的授權代理,提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們